Somaiya Mayur Ian

CIK 00017603032 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001760303

Recent Transactions

35 trades

Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-21$33.25/sh−15,422→ 82,744 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-21$9.26/sh+39,784→ 98,166 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (Right to Buy)
2026-01-21−39,784→ 662,814 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-21$33.80/sh−24,362→ 58,382 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-20$30.64/sh−900→ 117,698 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (Right to Buy)
2026-01-20−60,216→ 702,598 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-20$32.38/sh−19,604→ 58,382 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-20$31.78/sh−39,712→ 77,986 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-20$9.26/sh+60,216→ 118,598 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+25,500→ 58,382 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+115,000→ 115,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-05$33.25/sh−5,118→ 32,882 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (Right to Buy)
2025-01-28−14,900→ 762,814 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28$9.26/sh+14,900→ 52,900 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28−3,405→ 38,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28−11,495→ 41,405 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27−33,679→ 51,304 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27$9.26/sh+46,983→ 84,983 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (Right to Buy)
2025-01-27−46,983→ 777,714 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27−13,304→ 38,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+38,000→ 38,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-02+220,000→ 220,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-01-01+80,000→ 80,000 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-12-14$35.00/sh−2,000→ 1,473 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-12-14+2,000→ 102,558 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Common Stock
2020-12-14$5.88/sh+2,000→ 3,473 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-12-10+92,000→ 92,000 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-11-17−2,000→ 104,558 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Common Stock
2020-11-17$5.88/sh+2,000→ 5,139 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-11-17$30.00/sh−2,000→ 3,139 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-11-17$30.00/sh−1,666→ 1,473 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2020-02-28$10.10/sh+1,473→ 3,139 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-12-19−50,000→ 50,000 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2019-08-30$12.75/sh+1,666→ 1,666 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-04-11+152,307→ 152,307 total

Companies

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov